Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.15 -0.49 (-2.66%)
As of: Sep 30, 2026 · 10:25 AM EDT

Sarepta Therapeutics (SRPT) Total Non-Current Liabilities (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Total Non-Current Liabilities of $1.66 billion for Q2 2026, down 25.5% from $2.23 billion a year earlier and down 0.8% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Sarepta Therapeutics' Total Non-Current Liabilities came in at $2.21 billion, down 7.6% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 0.3% (FY2020 to FY2025).
  • In prior years, Sarepta Therapeutics' Total Non-Current Liabilities was $2.39 billion in FY2024 (+0.9%), $2.37 billion in FY2023 (-12.5%), $2.71 billion in FY2022 (+24.4%) and $2.18 billion in FY2021 (+0.2%).
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q4 2019.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last five quarters, with an average decline of 8.4% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2022, with growth of 25.1%; the weakest was Q2 2026, with a decline of 25.5%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $1.67 billion (Q1 2026), $2.21 billion (Q4 2025) and $2.14 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn 1.66 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Bn
Mar 31, 2026 1.67 Bn
Dec 31, 2025 2.21 Bn
Sep 30, 2025 2.14 Bn
Jun 30, 2025 2.23 Bn
Mar 31, 2025 2.23 Bn
Dec 31, 2024 2.39 Bn
Sep 30, 2024 2.33 Bn
Jun 30, 2024 2.30 Bn
Mar 31, 2024 2.21 Bn
Dec 31, 2023 2.37 Bn
Sep 30, 2023 2.31 Bn
Jun 30, 2023 2.35 Bn
Mar 31, 2023 2.31 Bn
Dec 31, 2022 2.71 Bn
Sep 30, 2022 2.69 Bn
Jun 30, 2022 2.23 Bn
Mar 31, 2022 2.16 Bn
Dec 31, 2021 2.18 Bn
Sep 30, 2021 2.15 Bn
API Access

Sarepta Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SRPT&period=max&api_key=YOUR_API_KEY